“Lebrikizumab Provides Progressive Improvements in Skin Clearance and Itch Relief Over One Year in Patients With Atopic Dermatitis”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s278. https://doi.org/10.25251/skin.7.supp.278.